These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29520231)

  • 21. High-quality and robust protein quantification in large clinical/pharmaceutical cohorts with IonStar proteomics investigation.
    Shen S; Wang X; Zhu X; Rasam S; Ma M; Huo S; Qian S; Zhang M; Qu M; Hu C; Jin L; Tian Y; Sethi S; Poulsen D; Wang J; Tu C; Qu J
    Nat Protoc; 2023 Mar; 18(3):700-731. PubMed ID: 36494494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways.
    Yang C; Mai Z; Liu C; Yin S; Cai Y; Xia C
    Molecules; 2022 May; 27(11):. PubMed ID: 35684449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-κB and Pancreatic Cancer; Chapter and Verse.
    Silke J; O'Reilly LA
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells.
    Niu J; Wang X; Qu J; Mager DE; Straubinger RM
    BMC Cancer; 2020 Oct; 20(1):1024. PubMed ID: 33097020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells.
    Veschi S; Ronci M; Lanuti P; De Lellis L; Florio R; Bologna G; Scotti L; Carletti E; Brugnoli F; Di Bella MC; Bertagnolo V; Marchisio M; Cama A
    Sci Rep; 2020 Feb; 10(1):2574. PubMed ID: 32054977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MS1 ion current-based quantitative proteomics: A promising solution for reliable analysis of large biological cohorts.
    Wang X; Shen S; Rasam SS; Qu J
    Mass Spectrom Rev; 2019 Nov; 38(6):461-482. PubMed ID: 30920002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic Drug-Drug Interactions.
    Niu J; Straubinger RM; Mager DE
    Clin Pharmacol Ther; 2019 Jun; 105(6):1395-1406. PubMed ID: 30912119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide inhibits Skp2 expression to increase chemosensitivity to gemcitabine in pancreatic cancer cells.
    Gao J; Wang G; Wu J; Zuo Y; Zhang J; Chen J
    Am J Transl Res; 2019; 11(2):991-997. PubMed ID: 30899398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts.
    Zhu X; Trueman S; Straubinger RM; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2018 Oct; 45(5):733-746. PubMed ID: 30069744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells.
    Zhu X; Shen X; Qu J; Straubinger RM; Jusko WJ
    Front Pharmacol; 2018; 9():84. PubMed ID: 29520231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways.
    Miao X; Koch G; Shen S; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
    J Pharm Sci; 2024 Jan; 113(1):235-245. PubMed ID: 37918792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells.
    Zhu X; Shen X; Qu J; Straubinger RM; Jusko WJ
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):549-561. PubMed ID: 30084546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated
    Wang X; Niu J; Li J; Shen X; Shen S; Straubinger RM; Qu J
    Mol Cell Proteomics; 2018 Apr; 17(4):655-671. PubMed ID: 29358341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome characterization of human pancreatic cyst fluid from intraductal papillary mucinous neoplasm by liquid chromatography/tandem mass spectrometry.
    Park J; Han D; Do M; Woo J; Wang JI; Han Y; Kwon W; Kim SW; Jang JY; Kim Y
    Rapid Commun Mass Spectrom; 2017 Oct; 31(20):1761-1772. PubMed ID: 28815810
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.